Variant report
| Variant | esv3388197 |
|---|---|
| Chromosome Location | chr3:151425407-151425727 |
| allele | n/a |
| Outlinks | Ensembl UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
Variant overlapped rSNPs/rCNVs (count:16 , 50 per page) page:
1
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs143276743 | chr3:151425434-151425435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs562447887 | chr3:151425441-151425442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs531468558 | chr3:151425445-151425446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs548408231 | chr3:151425488-151425489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs568160241 | chr3:151425501-151425502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs543706960 | chr3:151425528-151425529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs375858268 | chr3:151425535-151425536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs562152562 | chr3:151425540-151425541 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs111700707 | chr3:151425558-151425559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs5853537 | chr3:151425588-151425589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs199615797 | chr3:151425594-151425595 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs200987746 | chr3:151425595-151425596 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs116055224 | chr3:151425600-151425601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs566938043 | chr3:151425606-151425607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs184928655 | chr3:151425653-151425654 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs539037368 | chr3:151425660-151425661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Variant related diseases (count:52)
| Disease | PMID | Source |
|---|---|---|
| Basal cell lymphoma | 17053054 | CNVD |
| Esophageal cancer | 21851588 | CNVD |
| Uveal melanoma | 21693616 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Retinoblastoma | 21504564 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Thoracic aortic aneurysm | 21092924 | CNVD |
| Intellectual disability | 22102821 | CNVD |
| Autism | 22495311 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Squamous cell cancer | 20885788 | CNVD |
| Melanoma | 18172304 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Breast cancer | 22032731 | CNVD |
| Breast cancer | 16461572 | CNVD |
| Neuroblastoma | 17533364 | CNVD |
| Cervical Cancer | 21857958 | CNVD |
| Melanoma | 21693616 | CNVD |
| Lung cancer | 21426551 | CNVD |
| Cancer | 21637783 | CNVD |
| Cervical cancer | 21063398 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Oral cancer | 21386901 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| Cancer | 22065749 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Basal cell lymphoma | 21115979 | CNVD |
| head and neck squamous cell carcinoma | 17671120 | CNVD |
| Hepatocellular carcinoma | 16750200 | CNVD |
| Esophageal squamous carcinoma | 18350619 | CNVD |
| Myelodysplastic syndrome | 21251322 | CNVD |
| Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Acute lymphoblastic leukemia | 21339820 | CNVD |
| Breast cancer | 21364760 | CNVD |
| Basal cell lymphoma | 17170743 | CNVD |
| Gastrointestinal stromal cancer | 20818650 | CNVD |
| Ovarian clear cell carcinoma | 19293255 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Myofibroblastic sarcoma | 19369631 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Lung cancer | 16773561 | CNVD |
| Non-small cell lung cancer | 19010865 | CNVD |
| abnormal development | 18461090 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Uveal melanoma | 20484589 | CNVD |
| Breast cancer | 21509527 | CNVD |
| Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr3:151424800-151427800 | Enhancers | NH-A | brain |
| 2 | chr3:151425200-151425800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
| 3 | chr3:151425200-151426200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
| 4 | chr3:151425400-151425800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
| 5 | chr3:151425600-151427000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
